Michael Zimmerer
Family Medicine · Zanesville, OHNPI 1760468268
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 30.7% of the total. Reporting peaked in 2019 at $935 and has fallen 98.5% since, to $14 in 2023.
Across 149 payments — averaging $14.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$676
- AstraZeneca$278
- Amgen$223
- Amarin Pharma, Inc.$183
- Abbott$138
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$97
- plus $606 from 21 others
What the payments were for
- Food & beverage$2,18899%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $676 |
| AstraZeneca | 9 | $278 |
| Amgen | 17 | $223 |
| Amarin Pharma, Inc. | 13 | $183 |
| Abbott | 8 | $138 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $97 |
| GSK | 5 | $69 |
| Pfizer | 3 | $41 |
| Novartis | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $38 |
| Johnson & Johnson | 3 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Bayer | 2 | $31 |
| Mylan Specialty L.p. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Novo Nordisk | 2 | $27 |
| Merck | 2 | $26 |
| Lilly USA, LLC | 2 | $26 |
| Boehringer Ingelheim | 2 | $26 |
| Vivus LLC | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 2 | $23 |
| Radius Health, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$145
How this compares
$2,200 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Zanesville
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.